Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
about
Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study to Evaluate the Safety a ...... gic Malignancies (MK-4280-003)
@en
type
label
Study to Evaluate the Safety a ...... gic Malignancies (MK-4280-003)
@en
prefLabel
Study to Evaluate the Safety a ...... gic Malignancies (MK-4280-003)
@en
P17
P1050
P1476
A Phase 1/Phase 2 Clinical Stu ...... With Hematologic Malignancies
@en
P3098
NCT03598608
P4844
P580
2018-10-17T00:00:00Z
P582
2025-07-18T00:00:00Z